Therapeutic Challenges to Retinitis Pigmentosa
Author Information
Author(s): Sahni Jayashree N, Angi Martina, Irigoyen Cristina, Semeraro Francesco, Romano Mario R, Parmeggiani Francesco
Primary Institution: Royal Liverpool University Hospital
Hypothesis
Can advances in understanding the mechanisms of retinitis pigmentosa lead to effective therapies?
Conclusion
Current treatments for retinitis pigmentosa aim to slow degeneration and manage symptoms, but no therapy can yet restore vision.
Supporting Evidence
- Vitamin A supplementation has been suggested to slow down retinal degeneration.
- Gene therapy has shown promise in animal models for treating retinitis pigmentosa.
- Neuroprotective strategies aim to prolong photoreceptor viability.
Takeaway
Retinitis pigmentosa is a disease that affects vision, and while there are some treatments to help, none can fully fix the problem yet.
Methodology
This review summarizes current clinical management and future treatment possibilities for retinitis pigmentosa.
Limitations
There is no approved therapy to stop the progression of retinitis pigmentosa or restore vision, and many treatments lack convincing evidence of effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website